bf/NYSE:EVH_icon.jpeg

NYSE:EVH

Evolent Health, Inc.

  • Stock

USD

Last Close

29.56

25/09 14:39

Market Cap

2.22B

Beta: 1.54

Volume Today

698.73K

Avg: 941.80K

PE Ratio

−36.42

PFCF: 61.17

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-10.19M
-
-30.51M
199.38%
-21.95M
28.06%
37.63M
271.43%
-35.79M
195.11%
-297.59M
731.58%
-376.66M
26.57%
-362.07M
3.87%
-207.96M
42.56%
average payables
988K
-
8.35M
745.09%
30.30M
262.84%
43.41M
43.29%
94.84M
118.48%
92.12M
2.87%
34.78M
62.25%
64.08M
84.24%
76.63M
19.59%
52.71M
31.21%
average receivables
5.26M
-
10.19M
93.74%
30.51M
199.38%
54.79M
79.60%
75.63M
38.03%
79.86M
5.60%
101.87M
27.55%
128.46M
26.11%
192.64M
49.96%
350.72M
82.05%
book value per share
0.81
-
-0.05
106.67%
25.84
47,819.36%
15.60
39.63%
15.71
0.69%
14.79
5.85%
11.20
24.28%
7.30
34.85%
8.06
10.47%
9.17
13.81%
11.20
22.12%
capex per share
-0.27
-
-0.29
5.71%
-0.26
10.18%
-0.34
32.99%
-0.43
25.51%
-0.51
18.17%
-0.43
15.64%
-0.35
19.56%
-0.29
16.36%
-0.41
41.04%
-3.75
815.52%
capex to depreciation
-8.64
-
-0.91
-
-0.90
0.85%
-0.86
4.56%
-0.89
3.27%
-0.58
34.34%
-0.48
17.82%
-0.42
13.20%
-0.57
37.19%
-4.31
655.23%
capex to operating cash flow
0.77
-
0.15
80.81%
0.33
123.61%
0.44
33.07%
1.00
127.81%
1.92
92.27%
0.83
56.49%
1.82
118.00%
-0.64
135.49%
3.32
614.98%
-2.92
188.08%
capex to revenue
-0.41
-
-0.07
-
-0.06
9.17%
-0.06
4.82%
-0.06
1.49%
-0.04
33.44%
-0.03
31.34%
-0.03
4.55%
-0.03
3.12%
-0.21
648.34%
cash per share
1.78
-
6.17
-
3.97
35.66%
4.67
17.67%
2.96
36.62%
1.25
57.87%
4.05
224.81%
3.97
2.01%
2.16
45.56%
1.86
14.16%
days of inventory on hand
-129.60
-
-95.58
26.25%
-4.42
95.38%
87.42
2,077.59%
-106.77
222.14%
-231.63
116.94%
-171.09
26.14%
-146.62
14.30%
0.00
100.00%
days payables outstanding
24.03
-
106.19
-
103.24
2.78%
58.17
43.65%
163.40
180.88%
26.67
83.68%
16.69
37.43%
53.34
219.59%
20.15
62.21%
11.71
41.88%
days sales outstanding
149.58
-
76.79
-
58.35
24.01%
57.86
0.84%
47.91
17.19%
33.39
30.32%
45.09
35.07%
52.50
16.43%
68.76
30.96%
83.03
20.76%
debt to assets
0.10
-
0.10
-
0.09
7.75%
0.06
38.19%
0.25
330.70%
0.26
6.66%
0.20
24.75%
0.26
32.60%
0.23
13.59%
debt to equity
0.33
-
0.17
-
0.12
29.86%
0.09
28.33%
0.40
364.57%
0.58
45.23%
0.40
30.37%
0.55
37.01%
0.49
12.11%
dividend yield
0.01
-
0.00
96.28%
0.01
936.31%
0.01
9.59%
earnings yield
0.03
-
-0.04
226.09%
1.09
3,220.19%
-0.24
121.94%
-0.08
68.02%
-0.03
55.47%
-0.41
1,101.19%
-0.25
40.11%
-0.01
94.82%
-0.01
44.11%
-0.04
444.68%
enterprise value
653.07M
-
720.96M
10.40%
158.59M
78.00%
652.18M
311.25%
674.48M
3.42%
1.54B
127.67%
1.01B
34.02%
1.38B
36.27%
2.40B
73.51%
2.92B
21.84%
4.13B
41.37%
enterprise value over ebitda
-9.87
-
-28.56
189.45%
-0.35
98.77%
6.74
2,010.87%
-16.86
350.36%
-186.00
1,003.07%
-15.48
91.68%
58.52
478.13%
26.53
54.66%
396.60
1,394.67%
0.12
99.97%
ev to operating cash flow
-47.92
-
-9.60
79.96%
-8.00
16.70%
-18.37
129.64%
-24.12
31.35%
-74.36
208.23%
-23.76
68.05%
-85.10
258.17%
61.83
172.66%
-252.66
508.65%
28.94
111.45%
ev to sales
25.44
-
1.64
-
2.57
56.74%
1.55
39.56%
2.45
57.92%
1.20
51.12%
1.35
12.81%
2.64
95.39%
2.16
18.17%
2.10
2.68%
free cash flow per share
-0.63
-
-2.25
257.87%
-1.05
53.47%
-1.13
8.11%
-0.87
23.48%
-0.78
10.24%
-0.95
21.94%
-0.54
43.31%
0.16
129.72%
-0.53
433.10%
-2.47
363.03%
free cash flow yield
-0.03
-
-0.12
257.87%
-0.09
27.54%
-0.08
11.54%
-0.07
7.93%
-0.04
44.66%
-0.10
168.80%
-0.03
68.00%
0.01
117.22%
-0.02
428.24%
-0.07
293.64%
graham net net
0.13
-
-1.06
931.90%
3.16
399.11%
-2.19
169.40%
1.31
159.95%
-2.62
299.65%
-5.87
123.70%
-6.29
7.20%
-5.11
18.70%
-8.24
61.18%
-8.02
2.64%
graham number
3.09
-
0.90
71.00%
87.71
9,677.75%
35.29
59.77%
18.25
48.27%
15.05
17.54%
30.57
103.12%
25.42
16.87%
7.99
68.57%
6.42
19.65%
17.95
179.72%
income quality
-0.68
-
2.97
537.00%
-0.06
102.08%
0.16
352.55%
0.40
155.92%
0.38
4.90%
0.14
63.38%
0.05
65.22%
-1.03
2,222.85%
0.60
158.50%
-1.26
309.23%
intangibles to total assets
0.02
-
0.02
9.51%
0.76
4,397.76%
0.74
2.93%
0.66
10.25%
0.64
3.29%
0.59
8.23%
0.45
22.67%
0.50
9.44%
0.64
28.94%
0.72
12.82%
interest coverage
-146.66
-
-328.38
123.90%
-20.03
93.90%
-8.66
56.78%
-8.28
4.31%
-1.34
83.86%
1.19
188.99%
-3.84
422.98%
-649.97
16,815.37%
interest debt per share
0.27
-
0.01
-
2.69
22,946.39%
1.94
27.70%
1.34
30.84%
4.65
246.33%
4.57
1.81%
3.55
22.23%
5.25
47.65%
4.97
5.35%
inventory turnover
-2.82
-
-3.82
35.60%
-82.57
2,062.27%
4.18
105.06%
-3.42
181.87%
-1.58
53.90%
-2.13
35.39%
-2.49
16.69%
1.50B
60,391,776,115.16%
invested capital
0.33
-
0.17
-
0.12
29.86%
0.09
28.33%
0.40
364.57%
0.58
45.23%
0.40
30.37%
0.55
37.01%
0.49
12.11%
market cap
720.96M
-
720.96M
0%
304.31M
57.79%
666.46M
119.00%
791.52M
18.76%
1.54B
94.93%
745.39M
51.69%
1.36B
82.64%
2.38B
74.93%
2.63B
10.48%
3.67B
39.66%
net current asset value
9.36M
-
-39.27M
519.54%
103.53M
363.61%
-22.76M
121.98%
111.79M
591.19%
-44.96M
140.22%
-340.17M
656.62%
-204.45M
39.90%
-201.87M
1.26%
-479.82M
137.69%
-750.51M
56.41%
net debt to ebitda
1.03
-
0.32
-
-0.15
145.53%
2.93
2,084.11%
0.88
69.87%
-4.09
563.95%
0.82
119.99%
0.16
80.78%
39.12
24,795.22%
0.01
99.97%
net income per share
0.52
-
-0.66
226.09%
13.23
2,103.47%
-3.55
126.81%
-0.94
73.42%
-0.68
27.77%
-3.71
444.90%
-3.94
6.08%
-0.35
91.06%
-0.20
43.28%
-1.28
540.69%
operating cash flow per share
-0.36
-
-1.96
450.99%
-0.79
59.83%
-0.79
0.07%
-0.43
44.91%
-0.27
38.54%
-0.52
93.90%
-0.19
63.10%
0.45
335.65%
-0.12
127.39%
1.28
1,139.44%
payables turnover
15.19
-
3.44
-
3.54
2.86%
6.27
77.47%
2.23
64.40%
13.69
512.69%
21.87
59.81%
6.84
68.71%
18.11
164.63%
31.16
72.07%
receivables turnover
2.44
-
4.75
-
6.26
31.60%
6.31
0.85%
7.62
20.76%
10.93
43.50%
8.09
25.96%
6.95
14.11%
5.31
23.64%
4.40
17.19%
research and ddevelopement to revenue
0.01
-
return on tangible assets
0.20
-
-0.67
436.41%
1.37
303.56%
-0.51
137.21%
-0.14
73.07%
-0.09
37.86%
-0.49
481.84%
-0.45
9.63%
-0.04
90.51%
-0.03
32.41%
-0.19
569.20%
revenue per share
0.67
-
3.86
-
5.64
46.42%
6.76
19.74%
8.11
19.96%
10.28
26.74%
12.04
17.15%
10.55
12.37%
14.43
36.78%
17.65
22.34%
roe
0.64
-
12.20
1,790.91%
0.51
95.80%
-0.23
144.41%
-0.06
73.61%
-0.05
23.29%
-0.33
619.65%
-0.54
62.83%
-0.04
91.91%
-0.02
50.16%
-0.11
424.64%
roic
-0.51
-
12.20
2,483.80%
-0.06
100.51%
-0.28
346.83%
-0.06
78.68%
-0.04
34.89%
-0.08
115.24%
-0.04
56.61%
0.03
182.82%
-0.01
143.56%
26.72
207,434.28%
sales general and administrative to revenue
0.61
-
0.78
-
0.63
18.65%
0.47
25.20%
0.49
3.30%
0.46
4.99%
0.30
34.56%
0.24
20.41%
shareholders equity per share
0.81
-
-0.05
106.67%
25.84
47,819.36%
15.60
39.63%
15.71
0.69%
14.79
5.85%
11.20
24.28%
7.30
34.85%
8.06
10.47%
9.17
13.81%
11.20
22.12%
stock based compensation to revenue
0.00
-
0.15
-
0.09
41.78%
0.05
46.92%
0.03
40.24%
0.02
34.29%
0.01
22.58%
0.02
28.84%
0.03
36.56%
0.02
17.95%
tangible asset value
29.47M
-
-2.72M
109.22%
162.52M
6,081.74%
26.62M
83.62%
176.86M
564.33%
86.20M
51.26%
48.52M
43.71%
-3.21M
106.61%
-12.45M
288.27%
-306.14M
2,359.36%
-693.32M
126.47%
tangible book value per share
0.77
-
-0.07
109.22%
6.47
9,199.55%
0.59
90.86%
2.75
364.88%
1.11
59.45%
0.59
47.14%
-0.04
106.41%
-0.14
283.13%
-3.27
2,159.04%
-6.23
90.74%
working capital
50.97M
-
173K
99.66%
124.96M
72,129.48%
133.03M
6.46%
245.48M
84.54%
341.21M
38.99%
36.03M
89.44%
144.35M
300.63%
78.47M
45.64%
44.61M
43.15%
9.43M
78.86%

All numbers in USD (except ratios and percentages)